KPCB XV Associates

KPCB XV Associates as of June 30, 2022

Portfolio Holdings for KPCB XV Associates

KPCB XV Associates holds 4 positions in its portfolio as reported in the June 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Rapt Therapeutics Common Stock (RAPT) 43.7 $24M 1.3M 18.25
Twilio Class A Common Stock (TWLO) 29.4 $16M 190k 83.81
Atara Biotherapeutics Common Stock (ATRA) 27.0 $15M 1.9M 7.79
Augmedix Common Stock (AUGX) 0.0 $999.979200 708.00 1.41